Pharmaceutical Composition Containing Celecoxib And Tramadol

Patent No. EP3323413 (titled "Pharmaceutical Composition Containing Celecoxib And Tramadol") was filed by YOO Young Pharm on Jun 29, 2016. The application was issued on Sep 2, 2020.

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

Company	Opposition Date	Representative
DEHMEL & BETTENHAUSEN PATENTANWALTE PARTMBB	Jun 2, 2021	PETERS

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

Date
Description

Get instant alerts for new documents

Mar 14, 2023
Communication to the parties concerning termination of the opposition proceedings - opposition rejected - no appeal lodged
Mar 14, 2023
Communication to the parties concerning the termination of the opposition proceedings (opponent)
Mar 9, 2023
Termination of the opposition proceedings with maintenance of patent
Nov 28, 2022
Advice of delivery
Nov 25, 2022
Advice of delivery
Nov 24, 2022
Decision of the Opposition Division and instruction
Nov 24, 2022
Decision rejecting the opposition
Nov 24, 2022
Decision rejecting the opposition
Nov 24, 2022
Grounds for the decision (Annex) - opposition
Nov 24, 2022
Means of redress
Nov 24, 2022
Scanned annex to a communication - opposition procedure
Nov 24, 2022
Transmittal of decision / summons - opposition
Nov 24, 2022
Transmittal of decision / summons - opposition
Oct 27, 2022
Notification concerning the date of oral proceedings
Oct 27, 2022
Notification concerning the date of oral proceedings
Oct 24, 2022
Brief communication - Opposition proceedings
Oct 19, 2022
(Electronic) Receipt
Oct 19, 2022
Letter accompanying subsequently filed items
Oct 19, 2022
Written submission in preparation to/during oral proceedings
Oct 13, 2022
Brief communication in opposition procedure - time limit
Sep 29, 2022
Brief communication - Opposition proceedings
Sep 26, 2022
(Electronic) Receipt
Sep 26, 2022
(Electronic) Receipt
Sep 26, 2022
Auxiliary request during Opposition procedure
Sep 26, 2022
Auxiliary request during Opposition procedure
Sep 26, 2022
Auxiliary request during Opposition procedure
Sep 26, 2022
Auxiliary request during Opposition procedure
Sep 26, 2022
Auxiliary request during Opposition procedure - 01
Sep 26, 2022
Auxiliary request during Opposition procedure - 02
Sep 26, 2022
Auxiliary request during Opposition procedure - 03
Sep 26, 2022
Auxiliary request during Opposition procedure - 04
Sep 26, 2022
Description
Sep 26, 2022
Description
Sep 26, 2022
Description
Sep 26, 2022
Description
Sep 26, 2022
Letter accompanying subsequently filed items
Sep 26, 2022
Letter accompanying subsequently filed items
Sep 26, 2022
Request for interpreters during oral proceedings
Sep 26, 2022
Written submission in preparation to/during oral proceedings
May 2, 2022
Notification concerning the date of oral proceedings
May 2, 2022
Notification concerning the date of oral proceedings
Feb 9, 2022
Advice of delivery
Feb 9, 2022
Advice of delivery
Feb 7, 2022
Annex to the communication - opposition
Feb 7, 2022
Information concerning oral proceedings
Feb 7, 2022
Summons to attend oral proceedings
Feb 7, 2022
Summons to attend oral proceedings
Feb 7, 2022
Transmittal of decision / summons - opposition
Feb 7, 2022
Transmittal of decision / summons - opposition
Oct 28, 2021
Brief communication - Opposition proceedings
Oct 22, 2021
(Electronic) Receipt
Oct 22, 2021
Letter accompanying subsequently filed items
Oct 22, 2021
Reply of the patent proprietor to the notice(s) of opposition
Jun 17, 2021
Communication of a notice of opposition and request to file observations
Jun 17, 2021
Notice of further oppositions to opponent(s)
Jun 8, 2021
Communication of a notice of opposition - first information to patent proprietor
Jun 2, 2021
(Electronic) Receipt
Jun 2, 2021
Citation in opposition procedure - 001
Jun 2, 2021
Citation in opposition procedure - 002
Jun 2, 2021
Citation in opposition procedure - 003
Jun 2, 2021
Citation in opposition procedure - 003
Jun 2, 2021
Citation in opposition procedure - 004
Jun 2, 2021
Citation in opposition procedure - 005
Jun 2, 2021
Citation in opposition procedure - 005
Jun 2, 2021
Citation in opposition procedure - 006
Jun 2, 2021
Citation in opposition procedure - 006
Jun 2, 2021
Citation in opposition procedure - 007
Jun 2, 2021
Citation in opposition procedure - 008
Jun 2, 2021
Citation in opposition procedure - 009
Jun 2, 2021
Consolidated list of cited opposition documents
Jun 2, 2021
Notice of opposition
Jun 2, 2021
Notice of opposition
Sep 14, 2020
Transmission of the certificate for a European patent pursuant to Rule 74 EPC
Aug 6, 2020
Decision to grant a European patent
Jul 28, 2020
(Electronic) Receipt
Jul 28, 2020
Filing of the translations of the claims
Jul 28, 2020
French translation of claims
Jul 28, 2020
German translation of the claims
Jul 28, 2020
Letter accompanying subsequently filed items
Apr 14, 2020
Bibliographic data of the European patent application
Apr 14, 2020
Communication about intention to grant a European patent
Apr 14, 2020
Intention to grant (signatures)
Apr 14, 2020
Text intended for grant (clean copy)
Apr 14, 2020
Text intended for grant (version for approval)
Feb 24, 2020
(Electronic) Receipt
Feb 24, 2020
Amended claims with annotations
Feb 24, 2020
Claims
Feb 24, 2020
Description
Feb 24, 2020
Letter accompanying subsequently filed items
Feb 24, 2020
Reply to communication from the Examining Division
Dec 12, 2019
Annex to the communication
Dec 12, 2019
Consultation by telephone/in person (with time limit)
Dec 12, 2019
Result of consultation by telephone/in person
Dec 4, 2019
Examination started
Aug 30, 2019
(Electronic) Receipt
Aug 30, 2019
Amended claims filed after receipt of (European) search report
Aug 30, 2019
Amended claims with annotations
Aug 30, 2019
Amendments received before examination
Aug 30, 2019
Letter accompanying subsequently filed items
Aug 30, 2019
Non-patent literature cited during the examination procedure
Aug 30, 2019
Non-patent literature cited during the examination procedure
Feb 19, 2019
Invitation to declare maintenance of the application and to correct deficiencies in the Written Opinion/amend application
Jan 31, 2019
Communication regarding the transmission of the European search report
Jan 31, 2019
Document annexed to the Extended European Search Report
Jan 31, 2019
European search opinion
Jan 31, 2019
Information on Search Strategy
Jan 31, 2019
Supplementary European search report
Jan 17, 2019
Search started
Apr 25, 2018
Notification of forthcoming publication
Feb 21, 2018
Communication regarding possible amendment of the application/payment of claims fee
Feb 19, 2018
Communication to designated inventor
Feb 19, 2018
Communication to designated inventor
Feb 19, 2018
Communication to designated inventor
Jan 30, 2018
Copy of the international preliminary report on patentability
Jan 30, 2018
Translation of the international preliminary report on patentability
Jan 18, 2018
(Electronic) Receipt
Jan 18, 2018
Abstract
Jan 18, 2018
Amended drawings filed after receipt of (European) search report
Jan 18, 2018
Amendments received before examination
Jan 18, 2018
Claims
Jan 18, 2018
Description
Jan 18, 2018
Drawings
Jan 18, 2018
Request for entry into the European phase
Nov 24, 2017
Information on entry into European phase
Feb 7, 2017
Priority document (electronically transmitted)
Jan 19, 2017
Copy of the international search report
Jan 19, 2017
Copy of the translated international search report
Jan 19, 2017
International publication pamphlet

EP3323413

YOO YOUNG PHARM

Application Number: EP16824623A
Filing Date: Jun 29, 2016
Status: Opposition Rejected; Mar 10, 2023
Publication Date: Sep 2, 2020
External Links: Slate, Register , Google Patents

IP Verse

Pharmaceutical Composition Containing Celecoxib And Tramadol

Patent Summary

Patent Family

Patent Oppositions

Dossier Documents

EP3323413